Abbott Laboratories (ABT) Financials: Revenue & Earnings

ABT$115.51—
Medical - DevicesLarge Cap
Compare
Market cap$178.39BEnterprise value—Revenue (TTM)$48.23BMarket positionTop 25%

Score

45
Neutral
Value
44
Quality
52
Growth
38

Financial Summary

Abbott Laboratories (ABT) last printed $115.51. Equity value is $178.39B. Trailing earnings multiple 38.30. The revenue row is reported history.

Financials

2016201720182019202020212022202320242025
$20.85B$27.39B$30.58B$31.9B$34.61B$43.08B$43.65B$40.11B$41.95B$44.33B

Abbott Laboratories (ABT) Financials: Revenue & Earnings

ABT price $115.51 —

Ticker
ABT
Price
$115.51
Change
—
Market cap
$178.39B
P/E
38.30
Forward P/E
17.82
Dividend yield
2.18%
Beta
0.54
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
45
Value
44
Quality
52
Growth
38

Stocklytics score rationale: value 44, quality 52, growth 38.

AI Score 75. Abbott Laboratories has a solid market capitalization of approximately $199.9 billion and a stable beta of 0.54, indicating lower volatility. However, its high price-to-earnings ratio of 42.8 and a negative price-to-earnings growth ratio suggest that the stock may be overvalued relative to its earnings growth potential

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener